Utilizing Smart Storage RFID for manufacturing and inventory control of 48-hour Large Volume Delayed Sampling (LVDS) and Pathogen Reduced (PR) platelets as part of the new Food and Drug Administration Guidance to Industry. The session details planning, validating, and implementing a Smart Storage RFID system in the donor center and hospital. RFID allows for electronic tracking of component manufacturing time frames related LVDS and PR platelets in the donor center, as well as supports the hospital blood bank in managing multiple platelet inventories and selection of platelets for use in transfusion. The risk/cost benefit of implementing RFID includes monetary and intellectual allocation to innovation that is used in the non-pharmaceutical industry and applying this concept to manufacturing, distribution, and inventory control of blood components. Implementation requires a detailed evaluation of current processes to allow for a tailored implementation specific to each unique facility.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Evaluate the potential impact of Smart Storage RFID on platelet manufacturing strategies and hospital inventory control.
Discuss the regulatory aspect of manufacturing timeframes in relation to FDA Guidance to Industry with and without a Smart Storage RFID system.
Compare and contrast dual platelet inventory control with and without a Smart Storage RFID system.
Professor & Director/Chairman,
Hoxworth Blood Center, University of Cincinnati
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM21-55: The Impact of Using a Smart Storage Radio Frequency Identification (RFID) System on New Platelet Guidance Implementation and Compliance Evaluation